Aehr Test Systems
NASDAQ:AEHRSemiconductors
+$5.32 today
- Market cap
- $1.63B
- Beta
- 3.18
- P/E (TTM)
- -317.1
- EPS (TTM)
- -$0.37
Volume 2.27M
Average 2.97M
AEHR EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Aehr Test SystemsNASDAQ: AEHR
EBITDA · Q4 FY2026 · quarter ended May 2026
EBITDA turns positive
Q4 FY2026 EBITDA was $1.43M, compared with -$1.97M a year earlier. Trailing-twelve-month EBITDA was -$8.21M.
Context
- EBITDA amounted to 16.4% of revenue in FY2026, up 14.9 pp from a year earlier.
- EBITDA increased in 0 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of $35.54M (+533.2%) for the fiscal year ending May 2027, a step up from the -808.7% reported in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMay 2026
- $1.43M+145.6% QoQ
- Last fiscal yearMay 2026
- -$8.21M-808.7% YoY
- LTMMay 2026
- -$8.21M-808.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +172.9% | +255.7% | +82.8 pp |
| 1 year | -808.7% | +533.2% | +1341.9 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2026
- (8.21M) USD
- Year-over-year change
- -808.7%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2026 | 2026-05-29 | (8.21M) | -808.7% |
| FY2025 | 2025-05-30 | (903K) | -106.5% |
| FY2024 | 2024-05-31 | 13.82M | -8.3% |
| FY2023 | 2023-05-31 | 15.07M | +53.0% |
| FY2022 | 2022-05-31 | 9.85M | — |
EBITDA vs competitors
How AEHR compares with its peers on the latest reported figures
- AEHR's LTM May 2026 EBITDA of -$8.21M is the lowest of the 5 companies compared; the peer median is $124.55M.
- Its year-over-year change of -808.7% is the lowest of 5, against a peer median of +109.3%.
- EBITDA amounts to 16.1% of revenue for AEHR, versus a peer median of 14.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.52B | +131.3% | -5.3% | 34.1% | |
| LTM Sep 2026 | $227.78M | +87.3% | +6.0% | 23.2% | |
| LTM Jun 2026 | $21.32M | +175.6% | — | 4.1% | |
| LTM Mar 2026 | $3.11M | +0.1% | -22.1% | 5.3% | |
| LTM May 2026 | -$8.21M | -808.7% | — | 16.1% | |
| Peer median (excluding AEHR) | $124.55M | +109.3% | -5.3% | 14.3% | |
Competitors are the stored peer set for AEHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 May 2022 | FY2023 May 2023 | FY2024 May 2024 | FY2025 May 2025 | FY2026 May 2026 |
|---|---|---|---|---|---|
| Revenue | 50.83M | 64.96M | 66.22M | 58.97M | 50M |
| Cost of Revenue | 27.16M | 32.22M | 33.68M | 35.04M | 32.35M |
| Gross Profit | 23.67M | 32.75M | 32.54M | 23.93M | 17.65M |
| Gross Margin | 46.6% | 50.4% | 49.1% | 40.6% | 35.3% |
| Research & Development | 5.82M | 7.13M | 8.72M | 10.46M | 12.63M |
| Selling, General & Admin | 10.05M | 12.24M | 13.75M | 17.78M | 19.16M |
| Operating Expenses | 15.87M | 19.37M | 22.47M | 28.25M | 31.8M |
| Depreciation & Amortization | 307K | 450K | 1.36M | 3.39M | 3.53M |
| EBITDA | 9.85M | 15.07M | 13.82M | (903K) | (8.21M) |
| EBITDA Margin | 19.4% | 23.2% | 20.9% | -1.5% | -16.4% |
| Operating Income | 7.8M | 13.38M | 10.08M | (4.31M) | (14.15M) |
| Operating Margin | 15.3% | 20.6% | 15.2% | -7.3% | -28.3% |
| Interest Income | 13K | 1.25M | 2.39M | 1.4M | 1.36M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 1.74M | 1.24M | 2.38M | 22K | 2.41M |
| Income Before Tax | 9.54M | 14.62M | 12.46M | (4.29M) | (11.74M) |
| Pre-Tax Margin | 18.8% | 22.5% | 18.8% | -7.3% | -23.5% |
| Income Tax Expense | 91K | 60K | (20.7M) | (381K) | (4.61M) |
| Net Income | 9.45M | 14.56M | 33.16M | (3.91M) | (7.13M) |
| Net Margin | 18.6% | 22.4% | 50.1% | -6.6% | -14.3% |
| EPS (Basic) | 0.36 | 0.52 | 1.15 | (0.13) | (0.23) |
| EPS (Diluted) | 0.34 | 0.50 | 1.12 | (0.13) | (0.23) |
| Weighted Avg Shares | 26.01M | 27.79M | 28.82M | 29.58M | 30.67M |
| Weighted Avg Shares (Diluted) | 27.77M | 29.22M | 29.62M | 29.58M | 30.67M |
Aehr Test Systems
NASDAQ:AEHR
Intrinsic Alpha fair value
Locked
Current Price
$49.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.